Stock quote - Summary

Angle
AGL: 68.50 +1.00 ( +1.48 %) delayed: 15:48PM
Bid price 67.00 High price 68.00
Ask price 70.00 Low price 66.50
Open price 67.25 Spread 4.29%
Prev close 67.50 Volume 69,466

Angle - Share price charts

Intraday
Historic - 6 months

Advanced Angle charts >

Angle - Share price information
Name Angle Epic AGL
Activities ANGLE plc is a world-leading liquid biopsy company commercialising a disruptive platform technology that can capture cells circulating in blood, such as cancer cells, even when they are as rare in number as one cell in one billion blood cells, and harvest the cells for analysis. ANGLE's cell separation technology is called the ParsortixTM system and it enables a liquid biopsy (simple blood test) to be used to provide the cells of interest. Parsortix is the subject of granted patents in Europe, the United States, Canada, India, China, Japan and Australia and three extensive families of patents are being progressed worldwide. The system is based on a microfluidic device that captures live cells based on a combination of their size and compressibility. The ParsortixTM system has a CE Mark for Europe and FDA authorisation is in process for the United States. ANGLE has established formal collaborations with world-class cancer centres. ISIN GB0034330679
Latest Share Price (p) 68.50 Net Gearing (%) -28.70
Market Capitalisation (pm) 96.85 Gross Gearing (%) 13.12
Shares in issue (m) 143.49 Debt Ratio 0.00
P/E Ratio -6.69 Debt-to-Equity Ratio 0.00
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.15
Dividend Yield (%) 0.00 Price to book value 6.10
Dividend Cover 0.00 ROCE (%) -56.23
Earning per share (p) -10.09 EPS Growth (%) -15.84
52-week high / low (p) 78.50 / 38.00 DPS Growth (%) n/a
Angle - Broker views
Date Broker Recommendation Price Old target price New target price Notes
26 Apr finnCap Corporate 110.00 - Unchanged
18 Apr finnCap Corporate 110.00 - Unchanged
07 Mar finnCap Corporate 110.00 - Reiterates
28 Feb finnCap Corporate 110.00 - Reiterates
25 Feb finnCap Corporate 110.00 - Reiterates

More Angle broker views >

Angle - Director deals
Date Director Type Volume / Price Trade value
24 Sep 2009 Andrew Newland Buy 200,000 @ 15.25p £30,500.00

More Angle director deals >

Risk warning: Remember the price of shares can go down as well as up, and you are not guaranteed to get back the amount that you originally invested.
Click here to read the full warning.